The neurology devices market is projected to grow at a CAGR of 7.46% between 2024 and 2030, driven by the rising prevalence of brain injuries, dementia, Alzheimer’s disease, and other neurological disorders, alongside a growing geriatric population worldwide. According to the World Health Organization, roughly 55 million people were living with dementia in 2020, while around 8.5 million had Parkinson’s disease in 2019. As the global population ages — with the WHO projecting that one in six people will be 60 or older by 2030 — the demand for neurostimulation, neurosurgery, cerebrospinal fluid management, and interventional neurology devices continues to climb. The neurostimulation segment, which includes spinal cord stimulators used for chronic pain and movement disorders, holds a particularly strong revenue share thanks to recent regulatory approvals such as Abbott’s Proclaim Plus system and Nevro Corp’s 10 kHz high-frequency stimulation therapy. Key players shaping this space include Abbott, Medtronic, Boston Scientific, Stryker, and Koninklijke Philips, among others.
India Neurology Devices Market
Growth in this region is being propelled by improved healthcare access, supportive government initiatives for medical device innovation, and a rising burden of neurological conditions. As more patients require advanced diagnostic and treatment options, both domestic manufacturers and international companies are increasing their presence, with strategic partnerships and new product launches expected to accelerate momentum further.
UK Neurology Devices Market
A well-established healthcare system paired with strong clinical research capabilities continues to support growth here. Favorable regulatory frameworks and high adoption rates for advanced medical technologies, combined with rising healthcare spending and a focus on patient-centered care, position this market as a significant contributor to Europe’s broader neurology device industry.
Spain Neurology Devices Market
Positive momentum is being driven by greater public awareness, improved diagnostic capabilities, and healthcare reforms that support specialized treatment. Increased investment in dedicated neurology centers is expanding opportunities, and as device manufacturers broaden their regional footprint, sustained growth is expected.
Italy Neurology Devices Market
Italy’s aging population and established hospital infrastructure create steady demand for neurological diagnostic and treatment technologies. Ongoing modernization of healthcare facilities, combined with growing awareness of conditions like Parkinson’s disease and stroke, is encouraging hospitals to adopt more advanced neurostimulation and neurosurgery equipment, supporting the country’s role within the broader European market.
GCC Neurology Devices Market
Heavy government investment in healthcare modernization is fueling adoption of advanced neurological care solutions across the Gulf region. International collaborations, expanding infrastructure, and a growing number of specialized care centers are supporting this trajectory, with improving awareness and diagnosis rates expected to sustain upward growth.
Vietnam Neurology Devices Market
As healthcare infrastructure continues to develop across Southeast Asia, Vietnam is emerging as a growing market for neurological diagnostic and treatment devices. Rising awareness of neurological conditions, expanding hospital networks, and increasing investment from both domestic and international medical device companies are gradually improving access to advanced neurology care in the country.
Pediatric Neurology Device Market
Addressing the unique neurological needs of children, this is one of the fastest-growing segments within the broader industry. As early diagnosis becomes increasingly important for conditions affecting young patients, companies are prioritizing the development of safer, more effective devices tailored specifically for pediatric use, and rising case volumes are driving continued investment.
US Pediatric Neurology Devices Market
In the United States, the prevalence of traumatic brain injury remains a major growth driver — a brain injury occurs roughly every nine seconds, contributing to more than 3.5 million incidents annually, with about 2.8 million cases of traumatic brain injury reported each year and roughly 280,000 hospitalizations. Alongside this, around 60,000 Americans are diagnosed with Parkinson’s disease annually, and Alzheimer’s disease affects more than 6 million Americans today, a number projected to nearly double by 2050. These trends, combined with strong regulatory support and the presence of major device manufacturers, are fueling demand for pediatric-focused neurological diagnostic and treatment tools.
Europe Pediatric Neurology Device Market
Across Europe, rising awareness of early childhood neurological disorders, coupled with supportive reimbursement policies and healthcare reforms in countries like the UK, Spain, France, and Italy, is encouraging greater adoption of pediatric-specific neurology devices. Continued investment in specialized pediatric care centers and product innovation is expected to keep this segment on a strong growth path throughout the forecast period.
Overall, the convergence of an aging global population, rising neurological disease burden, technological innovation, and expanding regional healthcare investment is expected to keep the neurology devices industry on a steady growth trajectory through 2030.
Latest Reports Offered by Delveinsight
surgical robotic system market, t-cell blood cancer market, uncomplicated urinary tract infection market, uncomplicated urinary tract infections market, uterine fibroids market, wilson’s disease market, abdominal aortic aneurysm market, acromegaly market, actinic keratosis market, acute lung injury market, acute lymphocytic leukemia market, acute radiation syndrome market, adeno associated viruses aav gene therapy market, adeno-associated virus aav vectors in gene therapy market, adenosine deaminase-severe combined immunodeficiency market, adult myopia market, advanced liver cancer market, alopecia aerata market, alopecia market, anemia market, anorectal malformation market,
About Delveinsight
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk